What the name refers to
A synthetic analogue of the first 29 amino acids of growth-hormone-releasing hormone, with historical US approval and current compounded use.
Evidence and regulatory context
Medical use or authorisation exists historically or in limited jurisdictions. Current availability, indications and legal classification must be checked against the regulator for the reader’s location.
Reading product records
The record should distinguish a regulated medicine from a research-labelled analogue and state the exact molecule. For injectables, identity and quantity do not replace sterility, endotoxin, storage and batch-traceability information.
Primary research links
Use current regulator and study records rather than treating a catalogue description as medical evidence.